Genmab Acquires ADC Drug Developer ProfoundBio for US$1.8 B
By Lucy Haggerty
Pharma Deals Review: Vol 2024 Issue 4 (Table of Contents)
Published: 5 Apr-2024
DOI: 10.3833/pdr.v2024.i4.2868 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to bolster its oncology portfolio, Genmab has agreed to acquire ProfoundBio in an all-cash transaction for a total of US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS